Author | INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group | |
Access date | 2018-10-18T18:08:40Z | |
Available date | 2018-10-18T18:08:40Z | |
Document date | 2015 | |
Citation | The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Why START? Reflections That Led to the Conduct of This Large Long-Term Strategic HIV Trial. HIV medicine, v. 16, suppl 1, p. 1–9, 2015 | pt_BR |
ISSN | 1464-2662 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/29639 | |
Description | Presentes no INSIGHT Strategic Timing of AntiRetroviral Treatment Study Group: Beatriz Grinsztejn; Sandra Wagner Cardoso (Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil). | pt_BR |
Language | eng | pt_BR |
Rights | open access | pt_BR |
MeSH | Adult | pt_BR |
MeSH | Anti-Retroviral Agents | pt_BR |
MeSH | Antiretroviral Therapy | pt_BR |
MeSH | Highly Active | pt_BR |
MeSH | CD4 Lymphocyte Count | pt_BR |
MeSH | Cohort Studies | pt_BR |
MeSH | Female | pt_BR |
MeSH | HIV Infections | pt_BR |
MeSH | Humans | pt_BR |
MeSH | Male | pt_BR |
MeSH | Randomized Controlled Trials as Topic | pt_BR |
MeSH | Time Factors | pt_BR |
MeSH | Treatment Outcome | pt_BR |
Title | Why START? Reflections that led to the conduct of this large long-term strategic HIV trial | pt_BR |
Type | Article | pt_BR |
DOI | 10.1111/hiv.12227 | |
Subject | CD4-guided ART | pt_BR |
Subject | HIV | pt_BR |
Subject | START trial | pt_BR |
Subject | Antiretroviral therapy | pt_BR |
Subject | When to start | pt_BR |